Clinical Transplantation

Journal

Publication Venue For

  • Genome-wide association study for time to failure of kidney transplants from African American deceased donors.  34. 2020
  • Evaluation and care of international living kidney donor candidates: Strategies for addressing common considerations and challenges.  34. 2020
  • Vancomycin-resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.  33. 2019
  • Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation.  33. 2019
  • The effect of an organ procurement experience on preclinical medical student perceptions of transplant surgery.  33. 2019
  • Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus.  33. 2019
  • A quantitative appraisal of African Americans’ decisions to become registered organ donors at the driver’s license office.  32. 2018
  • Surgical approach, cost, and complications of appendectomy in kidney transplant recipients.  32. 2018
  • Lung transplantation in cystic fibrosis patients in Israel: The importance of ethnicity and nutritional status.  31. 2017
  • Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.  31. 2017
  • Patterns of primary care utilization before and after living kidney donation.  31. 2017
  • Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates.  31. 2017
  • Hormone resuscitation therapy for brain-dead donors – is insulin beneficial or detrimental?.  30:754-759. 2016
  • The case for xenotransplantation.  29:288-293. 2015
  • Assessment of resident and fellow knowledge of the organ donor referral process.  28:443-449. 2014
  • Infection and rejection risk after cardiac transplantation with induction vs. no induction: A multi-institutional study.  28:946-952. 2014
  • Radiation exposure and attributed cancer risk following lung transplantation.  28:324-329. 2014
  • Renal function preservation with the mTOR inhibitor, Everolimus, after lung transplant.  28:662-668. 2014
  • Ethnicity, medical insurance, and living kidney donation.  27. 2013
  • The relationship of socio-demographic factors and satisfaction with social support at five and 10 yr after heart transplantation.  27:267-273. 2013
  • Treatment options for renal cell carcinoma in renal allografts: A case series from a single institution.  27. 2013
  • Lung transplantation in patients with coal workers' pneumoconiosis.  26:629-634. 2012
  • Significance of C4d deposition in antibody-mediated rejection.  26:43-48. 2012
  • Beyond rose colored glasses: The adaptive role of depressive and anxious symptoms among individuals with heart failure who were evaluated for transplantation.  26. 2012
  • Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experience.  26:502-509. 2012
  • Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients.  26:105-110. 2012
  • Factors associated with work status at 5 and 10 years after heart transplantation.  25. 2011
  • Donor-recipient relationships in African American vs. Caucasian live kidney donors.  25. 2011
  • Short-term renal outcomes in African American and Caucasian donors following live kidney donation.  24:717-722. 2010
  • Impact of race and gender on live kidney donation.  23:39-46. 2009
  • Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.  22:113-119. 2008
  • Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: A 12-month randomized trial in renal transplant recipients.  21:192-201. 2007
  • Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation - A clinical and histological examination.  20:695-705. 2006
  • Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: A matched control study.  19:711-716. 2005
  • Laparoscopic donor nephrectomy vs. open live donor nephrectomy: A quality of life and functional study.  19:102-109. 2005
  • Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporin and steroids in renal transplantation.  17:511-517. 2003
  • Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management.  17:77-88. 2003
  • Fungal brain abscess in transplant recipients: Epidemiologic, microbiologic, and clinical features.  16:419-424. 2002
  • Improved outcomes in cadaveric renal allografts with pulsatile preservation.  14:543-549. 2000
  • Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.  14:533-542. 2000
  • Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapy.  14:439-448. 2000
  • Hepatitis C status of heart transplant recipients.  12:5-10. 1998
  • Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.  9:334-339. 1995
  • Angina pectoris in patients with cardiac transplants [1].  6:139-140. 1992
  • Immunosuppression tailored to race.  5:580-582. 1991
  • International Standard Serial Number (issn)

  • 0902-0063
  • Electronic International Standard Serial Number (eissn)

  • 1399-0012